Modulation of hepatic cytochrome P450 during Listeria monocytogenes infection of the brain

被引:14
作者
Cano, EGD [1 ]
Renton, KW [1 ]
机构
[1] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4H7, Canada
关键词
cytochrome P450; meningitis; Listeria monocytogenes; drug metabolism;
D O I
10.1002/jps.10433
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Hepatic cytochrome P450 enzymes can be modulated during systemic infections. Inflammatory responses in the brain have also been shown to cause a significant decrease in the levels and activities of important cytochrome P450 isoforms in the liver. We determined some of the effects of central nervous system (CNS) Listeria monocytogenes infection on hepatic cytochrome P450 systems in rats. Intracerebroventricular injection of L. monocytogenes resulted in a time-dependent modulation of CYP1A, CYP2B, and CYP3A activities in the liver. Total hepatic cytochrome P450 content was significantly lowered 48 h after administration of the bacterium, and hepatic CYP1A and CYP2B activities were significantly altered 48 and 72 h after infection, respectively, whereas CYP3A activity and protein content were depressed 72 h after the insult. Bacterial load in the brain increased dramatically over a 72-h period, but the number of bacteria cultured from liver over this time period was relatively small. Therefore, an infection largely confined to the CNS in the rat results in abnormal activity levels of certain hepatic cytochrome P450 enzymes crucial in drug metabolism. If such a response also occurs in humans, this has the potential to produce serious complications with drug and endogenous substrate metabolism in patients with an infectious disease involving the CNS. (C) 2003 Wiley-Liss, Inc. and the American Pharmacists Association.
引用
收藏
页码:1860 / 1868
页数:9
相关论文
共 30 条
[1]   Repeated oral dosing with Listeria monocytogenes in mice as a model of central nervous system listeriosis in man [J].
Altimira, J ;
Prats, N ;
López, S ;
Domingo, M ;
Briones, V ;
Domínguez, L ;
Marco, A .
JOURNAL OF COMPARATIVE PATHOLOGY, 1999, 121 (02) :117-125
[2]  
ARMSTRONG SG, 1993, MOL PHARMACOL, V43, P542
[3]  
AZRI S, 1987, J PHARMACOL EXP THER, V243, P1089
[4]   FACTORS INVOLVED IN THE DEPRESSION OF HEPATIC MIXED-FUNCTION OXIDASE DURING INFECTIONS WITH LISTERIA-MONOCYTOGENES [J].
AZRI, S ;
RENTON, KW .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1991, 13 (2-3) :197-204
[5]   ETHOXYPHENOXAZONES, PENTOXYPHENOXAZONES, AND BENZYLOXYPHENOXAZONES AND HOMOLOGS - A SERIES OF SUBSTRATES TO DISTINGUISH BETWEEN DIFFERENT INDUCED CYTOCHROMES-P-450 [J].
BURKE, MD ;
THOMPSON, S ;
ELCOMBE, CR ;
HALPERT, J ;
HAAPARANTA, T ;
MAYER, RT .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (18) :3337-3345
[6]  
Carpentier AF, 1996, REV NEUROL, V152, P587
[7]  
El Defrawy El Masry S., 1974, DRUG METAB DISPOS, V2, P267
[8]   DRUG-METABOLISM IN EXTRAHEPATIC DISEASES [J].
FARRELL, GC .
PHARMACOLOGY & THERAPEUTICS, 1987, 35 (03) :375-404
[9]  
Garcion E, 1998, GLIA, V22, P282, DOI 10.1002/(SICI)1098-1136(199803)22:3<282::AID-GLIA7>3.3.CO
[10]  
2-N